Novopor Advanced Science, a leading CDMO in performance chemicals and material science, has announced its acquisition of U.S.-based Pressure Chemical Company, a subsidiary of the Minafin Group known for its expertise in high-pressure and specialty chemistry. While the financial details of the deal remain confidential, the acquisition marks a strategic move by Novopor to enhance its specialty chemicals platform by integrating early-stage innovation with large-scale manufacturing.

With over 60 years of experience, Pressure Chemical, headquartered in Pittsburgh, Pennsylvania, is recognized for its capabilities in high-pressure chemistry, polymerization, and alkoxylation. The company specializes in process development, piloting, and low-volume manufacturing, making it a valuable addition to Novopor’s expanding operations.

Novopor aims to leverage this acquisition to invest further in infrastructure, technical capabilities, and customer-centric solutions. According to Novopor CEO Radhesh Welling, the deal boosts their capacity to support clients across the entire product lifecycle—from initial development to commercial-scale manufacturing.

Sandra Cernick, President of Pressure Chemical, expressed enthusiasm about the collaboration, highlighting how the partnership will enable expanded investment in people, facilities, and innovation.

Advisors involved in the transaction include KPMG, PwC, and Wombat Capital Markets for Novopor, and Fairmount Partners, Mazars, and Pierre Abitbol for Pressure Chemical. Legal counsel was provided by Honigman LLP, JSA, Clifford Chance LLP, and others.